跳至主要内容
临床试验/JPRN-UMIN000044521
JPRN-UMIN000044521尚未招募未知

Clinical evaluation on the pain-reducing effect of Aconinsan for burning mouth syndrome - Clinical evaluation on the pain-reducing effect of Aconinsan

Saga University0 个研究点目标入组 64 人开始时间: 2021年7月5日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patient suffer from Angle-closure Glaucoma 2)Patient have medical history of hypersensivity to prescription drug 3)Patient have medical history of cardiovascular disease and cerebrovascular disorder 4)Patient suffer from prostate disease 5)Patient who administered MAOI 6)Patient suffer from hyperthyroidism 7)Patient suffer from convulsive disorder 8)Patient suffer from manic depression 9)Patients with organic brain disorders or predisposition to schizophrenia 10)Patients who have or have had suicidal thoughts or suicide attempts 11)Patients taking other antidepressants, anti-epileptic drugs, anti-anxiety drugs, etc. 12)Patient who is judged inappropriate by doctor

研究者

相似试验